Glenmark Pharmaceuticals informs about media release

24 Jun 2025 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Pharmaceuticals Launches TEVIMBRA® in India: Expanding Access to Innovative ImmunoOncology Treatment for Non-Small Cell Lung Cancer and Esophageal Squamous Cell Carcinoma’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1959.00 -15.15 (-0.77%)
05-Dec-2025 15:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1521.50
Zydus Lifesciences 933.10
Lupin 2089.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×